Press Releases 2020
BOSTON SCIENTIFIC LAUNCHES WAVEWRITER ALPHA™ SPINAL CORD STIMULATOR SYSTEMS IN EUROPE-
SCS portfolio features full-body MRI conditional devices that combine therapy optionsfor personalized pain relief
Sept 30, 2020
Boston Scientific (NYSE: BSX) today announced the European launch of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) Systems. The portfolio, consisting of four MRI conditionali, Bluetooth-enabled implantable pulse generators (IPGs), offers expanded personalization based on patient needs, including rechargeable and non-rechargeable options, and access to waveforms that can cover multiple areas of pain…
BOSTON SCIENTIFIC LAUNCHES VERCISE GENUS™ DBS SYSTEM IN EUROPE-
Sept 10, 2020
Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark and initiated a limited market release of the fourth generation Vercise Genus™ Deep Brain Stimulation (DBS) System in Europe. Featuring full-body MRI conditionaland Bluetooth capabilities across the portfolio…
Media Contacts
Rainer Puster
Media Relations, Europe
+491754347057
Rainer.Puster@bsci.com
Rochelle Silsbee
Boston Scientific Global Neuromodulation
+1 (818) 812-7320
Rochelle.Silsbee@bsci.com